Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
Condition: Breast Cancer Interventions: Drug: TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen; Drug: Placebo capsules, Letrozole, Anastrozole, Tamoxifen Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Research | Study | Tamoxifen